PainChek General Discussion, page-203

First 203 Last

Share
Profile

Follow
rockboy

2,564 Posts.

223

23/03/18

17:12

Post #: 31987264
Share

Originally posted by RNClarke ↑

FDA all depends on the classification of the product, either way it will be in the bag by end of this year for eventual commercialisation in the US.

It is clear the near term goal is to have PainChek succeed in Australia, and then later this year expand into Europe. The market in Australia is very significant and I won't be disappointed if the EU rollout is delayed by a quarter or two.

It sounds like we will see a few deals strung together over the next few months as on boarding continues with the new Android Application complete.

From 5:40 in the interview PD mentions:
"We are working with a large number of residential aged care groups now, large ones, medium ones, small ones and we're basically looking to implement it in their care management systems throughout Australia"

Another clinical specialist coming on board in April to assist with technical support is a sign of the inbound demand to come, no point hiring a full time position if there isn't significant work ahead.

Having the in home consumer version out by mid year will only increase uptake of the application and something shareholders should look forward too. Whilst PCK have been quiet, the register has only been tightening.

Expand

nice one @RNClarke

sounds like plenty is happening in the background

love this bit:

patience will reward on this one, imo, but we may not have to wait toooo much longer

tick tock ...

PCK Price at posting: 7.0¢ Sentiment: Buy Disclosure: Held
8 Upvote

0 Great analysis

Reply

Top Stories

PAR

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Essential Energy conference: Streamlining approvals key to the green energy transition

HVN

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

88E

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

There are more pages in this discussion • 20,210 more messages in this thread...

First 203 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.2¢		Change -0.002(5.88%)		Mkt cap ! $52.34M

Open	High	Low	Value	Volume
3.3¢	3.3¢	3.2¢	$671	20.49K

Buyers (Bids)

No.	Vol.	Price($)
1	290642	3.2¢

Sellers (Offers)

Price($)	Vol.	No.
3.3¢	286624	3

View Market Depth

No.	Vol.	Price($)
1	290677	0.032
3	210857	0.031
8	1707000	0.030
6	9486448	0.029
2	125000	0.028

Price($)	Vol.	No.
0.033	286624	3
0.034	79638	2
0.035	152027	2
0.037	44589	1
0.038	271064	2

Last trade - 14.46pm 18/09/2024 (20 minute delay)

PCK (ASX) Chart

PainChek General Discussion, page-203

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Essential Energy conference: Streamlining approvals key to the green energy transition

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PainChek General Discussion, page-203

Top Stories

FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay?

Essential Energy conference: Streamlining approvals key to the green energy transition

Harvey Norman clocks subdued gains as Echo Law's junk warranty class action kicks off

BPM Minerals hits high-grade gold at the Claw Project WA; shares jump 86%

HotCopper users smell capital raising as 88 Energy says "significant update" at Phoenix

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News